Keros Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $615.9M
Liabilities Breakdown FY2024
Total Liabilities: $44.3M
Asset Breakdown
Total Assets: $615.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $559.9M | 90.9% |
| Accounts Receivable | $2.7M | 0.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.2M | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $49.0M | 8.0% |
Liabilities Breakdown
Total Liabilities: $44.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.6M | 10.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $39.7M | 89.6% |